Understanding Kaposi Sarcoma in HIV Patients in Africa
Official title: Kaposi Sarcoma in the Era of ART in Africa Program (KEAAP)
Funded at Lsu Health Sciences Center · NIH-10908991 · Data updated 2026-11-12
This study is working to improve how Kaposi sarcoma, a cancer often linked to HIV/AIDS, is diagnosed and treated in Zambia and Tanzania by bringing together different health organizations to better understand the disease and support patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $925,902 |
| NIH project number | 5U54CA277846-02 |
| Project ID | NIH-10908991 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living with HIV/AIDS, particularly those diagnosed with or at risk for Kaposi sarcoma in Zambia and Tanzania.
✕Less likely to help
Patients who do not have HIV/AIDS or those without any associated malignancies may not benefit from this research.
What this research studies
This research focuses on Kaposi sarcoma, a common cancer associated with HIV/AIDS, particularly in Zambia and Tanzania. It aims to build a collaborative network among various health institutions to improve the diagnosis, management, and prevention of this malignancy. The project will investigate the disease spectrum of Kaposi sarcoma, including its detection, care, outcomes, and the underlying immune responses. By enhancing research capacity in these regions, the program seeks to address critical gaps in understanding and treating this condition.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment options for patients with Kaposi sarcoma and other HIV-associated malignancies.
How similar studies have gone: Previous research has shown success in improving outcomes for HIV-associated malignancies through collaborative efforts, making this approach promising.
Where this research is happening
-
Lsu Health Sciences Center
New Orleans, United States Active
Researchers
- Principal investigator: Wood, Charles — Lsu Health Sciences Center
- Study coordinator: Wood, Charles
Related research
Other NIH-funded projects on the same topics.
-
Precision 3D Imaging to Monitor Kaposi Sarcoma (KS) with SkinScan3D
A new portable 3D imaging tool called SkinScan3D will help doctors measure KS skin lesions more accurately and quickly, especially in people living with HIV.
-
Precision 3D Imaging to Track Kaposi Sarcoma (KS) with SkinScan3D
A new 3D imaging tool called SkinScan3D helps doctors monitor Kaposi sarcoma lesions more accurately and quickly, especially in settings with high KS burden like East Africa and in U.S. clinics with HIV patients.
-
Kaposi Sarcoma care and research in Africa during ART era
A collaborative program to better understand and improve diagnosis, treatment, and prevention of Kaposi sarcoma for people living with HIV in Zambia and Tanzania.
-
Kaposi Sarcoma in Africa: ART Era Research Network
A collaborative program in Africa and the United States will study Kaposi sarcoma in people living with HIV on ART to improve diagnosis, treatment, and prevention.
-
Kaposi Sarcoma in Africa in the ART Era
This grant supports research to improve how Kaposi sarcoma is detected, treated, and understood in people living with HIV in Zambia and Tanzania during ART, with collaboration between African hospitals and a U.S. center.
-
Faster detection and connection to care for people with HIV who develop Kaposi sarcoma in East Africa
This project aims to speed up finding people with HIV diagnosed with Kaposi sarcoma in East Africa and help them get linked to care more quickly.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.